Recombinant Proteins With A Selective Inactivation Activity On Target Proteins


The present invention refers to a recombinant protein comprising a target-specific recognition domain and a degradation-inducing domain,said protein having a selective inactivation activity on target proteins, a genetic construct encoding the above protein, a vector and cell line comprising said genetic construct. The invention also refers to the above protein or genetic construct for use as a medicament, in particular for the treatment of any type of disease, where degradation of a defined secretory or membrane bound protein is required in order to ameliorate or cure the disease, more in particular said disease is a neurodegenerative disorder, a tumour, a genetic disease, a hypersensitivity disorder, a bacterial, parasitic or viral infection. The invention further refers to a pharmaceutical composition comprising said genetic construct and to the use of the above protein or of the genetic construct for the selective inactivation of target proteins.

Download PDF
Document Preview
Document History
  • Publication: May 31, 2012
  • Application: Nov 24, 2011
    WO IB 2011055274 W
  • Priority: Nov 25, 2010
    IT IT PD20100356 A

Download Citation

Sign in to the Lens